Gil Cisneros
Case file · Aug 5, 2025

Rep. Gil Cisneros bought $MSFT

Democrat House $1,001 - $15,000 Not disclosed Microsoft Corp [information-technology]

What Happened Next

$MSFT vs the S&P 500 from the trade date. A buy has an edge when the stock beats the market.

$MSFT · 30 days
−3.6%
S&P 500, same days
+3.4% −7.0 pts edge
$MSFT · 90 days
−1.9%
S&P 500, same days
+9.1% −11.0 pts edge
$MSFT · 180 days
−19.5%
S&P 500, same days
+11.4% −30.9 pts edge
Return
−20%−10%0+10%+20%+30%

The Paper Trail

Trade date
Aug 5, 2025
Disclosed
Sep 15, 2025 (38 days)
Shuffle Score
0/100
Filing
Not linked

Gil Cisneros's History in $MSFT

DateTypeAmountOwner
Jan 24, 2025 Buy $1,001 - $15,000 Not disclosed
Feb 26, 2025 Buy $15,001 - $50,000 Not disclosed
Mar 31, 2025 Sell $15,001 - $50,000 Not disclosed
Apr 29, 2025 Buy $15,001 - $50,000 Not disclosed
Aug 5, 2025 Buy $1,001 - $15,000 Not disclosed
Oct 9, 2025 Buy $1,001 - $15,000 Not disclosed
Nov 12, 2025 Buy $1,001 - $15,000 Not disclosed
Nov 18, 2025 Buy $50,001 - $100,000 Not disclosed
Dec 19, 2025 Sell $15,001 - $50,000 Not disclosed
Feb 10, 2026 Sell $15,001 - $50,000 Not disclosed
Mar 13, 2026 Buy $15,001 - $50,000 Not disclosed
Apr 14, 2026 Sell $15,001 - $50,000 Not disclosed
May 15, 2026 Buy $50,001 - $100,000 Not disclosed
Jun 16, 2026 Sell $15,001 - $50,000 Not disclosed
Jul 17, 2026 Buy $15,001 - $50,000 Not disclosed
Aug 18, 2026 Buy $15,001 - $50,000 Not disclosed

Who Else Traded $MSFT That Week

Other members of Congress with trades in the same stock within 7 days either side

PoliticianDateTypeAmount
Julie Johnson Dem Jul 29, 2025 Sell $1,001 - $15,000
Cleo Fields Dem Jul 29, 2025 Buy $100,001 - $250,000
Cleo Fields Dem Jul 29, 2025 Buy $50,001 - $100,000
Cleo Fields Dem Aug 1, 2025 Buy $100,001 - $250,000
Cleo Fields Dem Aug 1, 2025 Buy $100,001 - $250,000
Cleo Fields Dem Aug 1, 2025 Buy $50,001 - $100,000
Adam Smith Dem Aug 8, 2025 Sell $1,001 - $15,000

Returns use split- and dividend-adjusted closes. Disclosures report ranges, not exact amounts. A well-timed trade is not evidence of wrongdoing. Methodology · Disclaimer